These results are supported by previous studies in which the overexpression of MAGE-A6 was found to increase cell migration; in addition, MAGE-A6 knockdown was shown to reduce migration of glioma and esophageal cancer cells [81,82]. Here, MAGEA6 is linked to esophageal cancer.